Print

Services & Pricing

The goal of the BSF is to facilitate the integration of genomic methods into biomedical research, and to assist efforts aimed at integrating next generation sequencing into clinical diagnostics. The work of the BSF is subsidized by the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and by the Medical University of Vienna. These subsidies make it possible to offer certain services for free, and to provide next generation sequencing at discounted prices for academic and non-profit institutions in Austria. In addition, the BSF provides fee-for-service sequencing for academic and commercial customers, and it collaborates on grant-funded research both nationally and internationally.

Services

  • Research support and consulting for a broad range of applications of next generation sequencing in biomedicine
  • Sequencing service using the Illumina HiSeq platform (currently the preferred technology for many applications)
  • Advice and contacts for other sequencing technologies (e.g. Ion Torrent/Proton, Illumina MiSeq, Pacific Biosciences, Oxford Nanopore, Complete Genomics, Roche 454)
  • Automatized library preparation services (RNA-seq, exome-seq, whole genome sequencing)
  • Help and advice with additional protocols (e.g., ChIP-seq, DNA methylation, open chromatin, targeted validation sequencing, etc.)
  • Local point of contact for commercial providers of next generation sequencing technology
  • Bioinformatic data processing, analysis and assistance with data interpretation

Pricing

Download the price List for Collaborative Sequencing

Sequencing services. The most popular offer for academic labs is "collaborative sequencing", and the corresponding prices (please see the price list) are subsidized by the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and by the Medical University of Vienna. To ensure that these subsidies are used in the most effective way, collaborative sequencing comes with certain responsibilities for the user: (i) Appropriate measures must be taken to ensure that the study stands reasonable chances of success. Specifically, users may be requested by the BSF to provide a project abstract and/or a concrete bioinformatic analysis plan that documents the feasibility of the approach; (ii) Users must provide a sample annotation sheet with detailed documentation of the protocols used, in order to facilitate sequencing operations and error handling; (iii) the BSF coordinator must be informed prior to submission of any publications arising from collaborative sequencing (an informal e-mail with title, author list and abstract of the manuscript is sufficient), and the BSF must be acknowledged through co-authorship and/or a suitable sentence in the Acknowledgement section (jointly decided based on the scope and scale of the BSF contribution).

Fee-for-service sequencing. For projects that do not fit well with the criteria of subsidized "collaborative sequencing" (as described above), the BSF also offers fee-for-service sequencing for both academic and commercial users. Fee-for-service sequencing does not involve any direct subsidies, which is why fee-for-service sequencing does not constitute a formal collaboration with the BSF and also does not create any responsibilities on the user's side.Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. to request a quote for fee-for-service sequencing.

Advice & consulting. Initial consulting is always free of charge, for both academic and commercial users. Furthermore, for projects that are particularly well aligned with the goals of the BSF (e.g. development of a protocol that is of high relevance but currently not established at the BSF) it is possible that the BSF actively contributes to protocol development and mentors collaborating researchers in the implementation of next generation sequencing activities in their labs and institutes.

Bioinformatic analysis. Although the initial steps of bioinformatic analysis are usually performed by BSF staff, almost all projects need additional bioinformatic resources in order to analyze and interpret the sequencing data in a reasonable manner. For selected projects the BSF staff can assist with such analyses (on a collaborative basis), but the amount of support offered depends on the topic and typically requires some form of third-party funding (e.g., by applying for joint grants together with the BSF).

Additional services. RNA-seq services for researchers at the Medical University of Vienna are also available from Martin Bilban.